ASCI / Emerging-Generation Awards, 2023
The Emerging Generation Awards (E-Gen Awards) recognize post-MD, pre-faculty appointment physician-scientists who are meaningfully engaged in immersive research.
About the awardee
As a translational medical oncologist, Albert Eusik Kim, MD seeks to apply cancer biology and machine learning towards designing personalized, precision-based treatment paradigms for patients. As a trainee, Dr. Kim used functional imaging and tumor genomics in patients with brain metastases to identify predictive biomarkers of checkpoint inhibitor (ICI) response and resistance. Additionally, he oversees several single-cell profiling efforts to assess tumor microenvironmental influences for ICI intracranial response. Thus far, they have identified differential patterns of vascular remodeling and T cell phenotypes associated with ICI response/resistance. He also co-led the analysis of two phase II trials (Nature Cancer 2021, Nature Communications 2022). Now, as junior faculty, he is complementing his skillsets in Omics and clinical trial analysis with training in machine learning (ML) as another tool to study tumor biology. Dr. Kim’s long-term vision is to lead a translational multi-disciplinary group applying machine learning and Omics towards pre-clinical and clinical oncology questions.